Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article

Non-alcoholic fatty liver disease (NAFLD) has emerged as one of the lethal causes of chronic liver disease globally. NAFLD can ultimately progress to non-alcoholic steatohepatitis (NASH) given persistent cellular insult. The crux of the problem lies in fat accumulation in the liver, such as increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghazanfar, Haider, Kandhi, Sameer D, Nawaz, Iqra, Javed, Nismat, Abraham, Minu C, Farag, Mohamed, Mahasamudram, Jaydeep, Patel, Vishwa B, Altaf, Faryal, Patel, Harish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214471/
https://www.ncbi.nlm.nih.gov/pubmed/34164242
http://dx.doi.org/10.7759/cureus.15141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214471/
https://www.ncbi.nlm.nih.gov/pubmed/34164242
http://dx.doi.org/10.7759/cureus.15141

Ejemplares similares